{
    "info": {
        "nct_id": "NCT06423911",
        "official_title": "This is a Global, Multi-center, Open-label Randomized and Registrational Phase 3 Study of Olverembatinib (HQP1351) in Patients With Chronic Phase Chronic Myeloid Leukemia",
        "inclusion_criteria": "Patients eligible for inclusion in this study must meet all of the following criteria.\n\n1. Age ≥ 18 years old.\n2. Diagnosis of CML-CP\n3. Part A: Previously treated with at least two approved TKIs Part B: T315I mutation at screening.\n4. Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 2.\n5. Written informed consent obtained prior to any screening procedures.\n6. Patients with adequate organ functions\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
        "exclusion_criteria": "Patients eligible for this study must not meet any of the following criteria.\n\n1. For Part A only: T315I mutation at any time prior to starting study treatment.\n2. Active infection that requires systemic drug therapy\n3. Impairment of gastrointestinal (GI) function or GI disease that may significantly alter absorption of study drugs\n4. Previous treatment with or known / suspected hypersensitivity to olverembatinib or any of its excipients.\n5. Previous treatment with or known / suspected hypersensitivity to bosutinib or any of its excipients.\n6. Pregnant or nursing (lactating) women.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "5. Written informed consent obtained prior to any screening procedures.",
            "criterions": [
                {
                    "exact_snippets": "Written informed consent obtained prior to any screening procedures.",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "form",
                            "expected_value": "written"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to any screening procedures"
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Diagnosis of CML-CP",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of CML-CP",
                    "criterion": "CML-CP diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 2.",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 2.",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Part A: Previously treated with at least two approved TKIs Part B: T315I mutation at screening.",
            "criterions": [
                {
                    "exact_snippets": "Previously treated with at least two approved TKIs",
                    "criterion": "prior TKI treatment",
                    "requirements": [
                        {
                            "requirement_type": "number of approved TKIs previously treated with",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "T315I mutation at screening",
                    "criterion": "T315I mutation",
                    "requirements": [
                        {
                            "requirement_type": "presence at screening",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patients with adequate organ functions",
            "criterions": [
                {
                    "exact_snippets": "adequate organ functions",
                    "criterion": "organ functions",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Age ≥ 18 years old.",
            "criterions": [
                {
                    "exact_snippets": "Age ≥ 18 years old",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 99 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 99 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 99,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "2. Active infection that requires systemic drug therapy",
            "criterions": [
                {
                    "exact_snippets": "Active infection that requires systemic drug therapy",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": "requires systemic drug therapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Impairment of gastrointestinal (GI) function or GI disease that may significantly alter absorption of study drugs",
            "criterions": [
                {
                    "exact_snippets": "Impairment of gastrointestinal (GI) function",
                    "criterion": "gastrointestinal (GI) function",
                    "requirements": [
                        {
                            "requirement_type": "impairment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "GI disease that may significantly alter absorption of study drugs",
                    "criterion": "gastrointestinal (GI) disease",
                    "requirements": [
                        {
                            "requirement_type": "potential to significantly alter absorption of study drugs",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Pregnant or nursing (lactating) women.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant ... women",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "nursing (lactating) women",
                    "criterion": "nursing (lactating) status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Previous treatment with or known / suspected hypersensitivity to olverembatinib or any of its excipients.",
            "criterions": [
                {
                    "exact_snippets": "Previous treatment with ... olverembatinib",
                    "criterion": "previous treatment with olverembatinib",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known / suspected hypersensitivity to olverembatinib",
                    "criterion": "hypersensitivity to olverembatinib",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known / suspected hypersensitivity to ... any of its excipients",
                    "criterion": "hypersensitivity to olverembatinib excipients",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. For Part A only: T315I mutation at any time prior to starting study treatment.",
            "criterions": [
                {
                    "exact_snippets": "T315I mutation at any time prior to starting study treatment",
                    "criterion": "T315I mutation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "any time prior to starting study treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Previous treatment with or known / suspected hypersensitivity to bosutinib or any of its excipients.",
            "criterions": [
                {
                    "exact_snippets": "Previous treatment with ... bosutinib",
                    "criterion": "previous treatment with bosutinib",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known / suspected hypersensitivity to bosutinib",
                    "criterion": "hypersensitivity to bosutinib",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known / suspected hypersensitivity to ... any of its excipients",
                    "criterion": "hypersensitivity to bosutinib excipients",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Patients eligible for inclusion in this study must meet all of the following criteria.",
            "criterions": []
        }
    ],
    "failed_exclusion": [
        {
            "line": "Patients eligible for this study must not meet any of the following criteria.",
            "criterions": []
        }
    ],
    "failed_miscellaneous": []
}